Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10.8M
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
2.42M
-
Shares change
-
-64.1K
-
Total reported value, excl. options
-
$8.58M
-
Value change
-
-$195K
-
Put/Call ratio
-
0.08
-
Number of buys
-
13
-
Number of sells
-
-7
-
Price
-
$3.54
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q1 2025
35 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.42M shares
of 10.8M outstanding shares and own 22.48% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (1.21M shares), VANGUARD GROUP INC (364K shares), CM Management, LLC (200K shares), GEODE CAPITAL MANAGEMENT, LLC (90.5K shares), RENAISSANCE TECHNOLOGIES LLC (88.8K shares), NewEdge Advisors, LLC (59.9K shares), Voss Capital, LP (50K shares), BlackRock, Inc. (40.2K shares), Perigon Wealth Management, LLC (39.4K shares), and DIMENSIONAL FUND ADVISORS LP (37.5K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.